Ruoxi Hong

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment

Xi Wang, Shusen Wang, Heng Huang et al. · JAMA · 2020 · 230 citations · Full text

Medicine, Oncology, Pharmacology +17

SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer

Anjie Zhu, Peng Yuan, Feng Du et al. · Oncotarget · 2016 · 63 citations · Full text

Medicine, Cancer Biology, Oncology +11

Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries

Wenjie Zhu, Edith A. Perez, Ruoxi Hong et al. · PLoS ONE · 2015 · 50 citations · Full text

Medicine, Geriatric Medicine, Oncology +16

Preventing <scp>BRCA</scp>1/<scp>ZBRK</scp>1 repressor complex binding to the <i>GOT2</i> promoter results in accelerated aspartate biosynthesis and promotion of cell proliferation

Ruoxi Hong, Weimin Zhang, Xi Xia et al. · Molecular Oncology · 2019 · 47 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

CDK4/6 inhibitor palbociclib enhances the effect of pyrotinib in HER2-positive breast cancer

Kai Zhang, Ruoxi Hong, Kaping Lee et al. · Cancer Letters · 2019 · 47 citations

Medicine, Oncology, Pharmacology +14